Sign in

BioNTech SE

Income Statement - BioNTech SE (BNTX)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Total revenue 2.76 2.75 3.82 17.31 18.98 0.48 0.11 0.13 0.06
Cost of revenue 0.62 0.54 0.60 3.00 2.91 0.06 0.02 0.01 0.01
Gross profit 2.14 2.21 3.22 14.32 16.07 0.42 0.09 0.11 0.05
Total operating expenses + 2.76 3.52 2.53 1.67 0.78 0.51 0.27 0.17 0.11
Operating income -0.62 -1.31 0.69 12.64 15.28 -0.08 -0.18 -0.05 -0.06
Non-operating income (net) -0.39 0.64 0.50 0.31 -0.24 -0.06 0.00 0.01 -0.02
Income before tax -1.01 -0.68 1.19 12.95 15.05 -0.15 -0.18 -0.05 -0.09
Income tax expense 0.08 -0.01 0.26 3.52 4.75 -0.16 0.00 0.00 0.00
Net income -1.09 -0.67 0.93 9.43 10.29 0.02 -0.18 -0.05 -0.09
Show Quarterly Income Statement

Income Statement - BioNTech SE (BNTX)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Total revenue 0.12 0.90 1.52 0.26 0.18 1.19 1.24 0.13 0.19 1.48 0.90 0.17 1.28 4.28 3.46 3.20 6.37 5.53 6.09 5.31 2.05 0.35 0.07 0.04 0.03 0.03 0.03 0.03 0.03 0.06 0.02 0.02 0.02
Cost of revenue 0.20 0.33 0.15 0.08 0.08 0.24 0.18 0.06 0.06 0.18 0.16 0.16 0.10 0.18 0.75 0.76 1.29 0.58 1.21 0.88 0.23 0.04 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Gross profit -0.08 0.57 1.37 0.18 0.10 0.95 1.07 0.07 0.13 1.30 0.73 0.00 1.18 4.09 2.71 2.43 5.08 4.95 4.88 4.42 1.82 0.30 0.06 0.04 0.02 0.02 0.02 0.02 0.02 0.06 0.02 0.02 0.02
Total operating expenses + 0.60 0.80 1.42 0.69 0.63 0.80 1.06 1.04 0.64 0.77 0.66 0.57 0.53 0.80 0.32 0.22 0.33 0.25 0.15 0.23 0.15 0.06 0.25 0.12 0.08 0.08 0.06 0.07 0.07 0.06 0.04 0.03 0.03
Operating income -0.67 -0.23 -0.05 -0.50 -0.53 0.15 0.01 -0.97 -0.51 0.53 0.07 -0.56 0.65 3.29 2.39 2.21 4.75 4.70 4.72 4.20 1.66 0.24 -0.19 -0.08 -0.06 -0.05 -0.04 -0.05 -0.04 0.00 -0.02 -0.01 -0.01
Non-operating income (net) 0.09 0.01 0.07 0.10 0.09 0.15 0.15 0.16 0.18 0.14 0.15 0.15 0.05 -0.12 0.06 0.11 0.27 0.01 -0.06 -0.18 -0.02 -0.04 -0.02 -0.01 0.01 -0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.58 -0.23 0.02 -0.40 -0.45 0.30 0.16 -0.81 -0.33 0.66 0.23 -0.41 0.71 3.17 2.44 2.32 5.02 4.71 4.67 4.02 1.64 0.21 -0.21 -0.09 -0.05 -0.06 -0.03 -0.05 -0.04 0.00 -0.02 -0.01 -0.01
Income tax expense -0.04 0.08 0.05 -0.02 -0.03 0.04 -0.04 0.00 -0.02 0.21 0.07 -0.22 0.21 0.89 0.66 0.65 1.32 1.55 1.46 1.24 0.51 -0.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.54 -0.30 -0.03 -0.39 -0.42 0.26 0.20 -0.81 -0.32 0.46 0.16 -0.19 0.50 2.28 1.78 1.67 3.70 3.17 3.21 2.79 1.13 0.37 -0.21 -0.09 -0.05 -0.06 -0.03 -0.05 -0.04 0.00 -0.02 -0.01 -0.01
about 2 months ago

Balance Sheet - BioNTech SE (BNTX)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Total cash and short-term investments + 14.83 16.78 16.55 14.06 2.07 1.35 0.52 0.41 0.17 0.31
Accounts receivable, net 0.98 1.52 2.34 7.15 12.38 0.17 0.02 0.03 0.00 0.01
Inventories 0.11 0.28 0.36 0.44 0.50 0.06 0.01 0.01 0.00 0.00
Other current assets 0.21 0.21 0.28 0.27 0.11 0.09 0.00 0.01 0.01 0.00
Total current assets 16.14 18.80 19.53 21.92 15.07 1.67 0.56 0.45 0.19 0.32
Total non-current assets + 5.84 3.73 3.48 1.36 0.76 0.65 0.24 0.20 0.19 0.07
Total assets 21.98 22.53 23.01 23.28 15.83 2.32 0.80 0.65 0.37 0.39
Total current liabilities + 2.14 2.52 2.07 2.95 3.48 0.61 0.14 0.13 0.16 0.06
Total non-current liabilities + 0.62 0.60 0.69 0.27 0.46 0.34 0.17 0.26 0.26 0.30
Total liabilities 2.76 3.12 2.76 3.22 3.94 0.95 0.30 0.39 0.42 0.36
Total stockholders' equity + 19.22 19.41 20.25 20.06 11.89 1.37 0.49 0.27 -0.05 0.03
Common shares outstanding 242 240 243 250 260 249 211 227 227 0
Show Quarterly Balance Sheet

Balance Sheet - BioNTech SE (BNTX)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Total cash and short-term investments + 14.65 14.83 14.53 14.04 14.11 16.78 16.71 17.30 15.67 16.55 15.75 15.56 13.55 14.06 13.43 9.33 6.17 2.07 2.77 0.91 0.89 1.35 1.01 0.57 0.45 0.52 0.46 0.48 0.41 0.41 0.00 0.00 0.17
Accounts receivable, net 0.61 0.98 0.70 1.45 1.03 1.52 1.20 0.29 1.93 2.16 2.01 2.66 7.59 7.15 7.31 10.38 12.70 12.38 12.29 7.05 2.40 0.17 0.01 0.01 0.01 0.01 0.01 0.01 0.03 0.02
Inventories 0.10 0.11 0.23 0.23 0.25 0.28 0.30 0.34 0.35 0.36 0.42 0.45 0.46 0.44 0.29 0.37 0.46 0.50 0.46 0.31 0.15 0.06 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01
Other current assets 0.18 0.21 0.38 0.22 0.23 0.21 0.28 0.36 0.34 0.46 0.58 0.54 0.58 0.27 0.24 0.12 0.15 0.11 0.13 0.17 0.10 0.09 0.05 0.02 0.01 0.02 0.02 0.01 0.04 0.01
Total current assets 15.55 16.14 15.83 15.93 15.63 18.80 18.49 18.28 18.27 19.53 18.75 19.21 21.82 21.92 21.27 20.21 19.47 15.07 15.65 8.44 3.54 1.67 1.09 0.62 0.49 0.56 0.50 0.50 0.41 0.45 0.17
Total non-current assets + 5.55 5.84 5.51 5.71 5.56 3.73 3.92 3.96 3.98 3.48 3.46 3.01 2.17 1.36 1.39 0.95 0.83 0.76 0.85 0.71 0.67 0.65 0.36 0.35 0.24 0.24 0.24 0.22 -0.41 0.20 -0.17
Total assets 21.10 21.98 21.34 21.64 21.18 22.53 22.40 22.24 22.26 23.01 22.21 22.23 23.99 23.28 22.66 21.16 20.30 15.83 16.49 9.15 4.20 2.32 1.45 0.97 0.73 0.80 0.74 0.72 2.27 0.65
Total current liabilities + 1.77 2.14 2.22 1.85 1.53 2.52 2.52 2.43 1.61 2.07 1.81 1.82 1.68 2.95 3.96 3.92 3.85 3.48 5.68 3.16 1.31 0.61 0.27 0.21 0.14 0.14 0.13 0.14 0.43 0.13
Total non-current liabilities + 0.61 0.62 0.64 1.28 0.72 0.60 0.76 0.74 0.68 0.69 0.53 0.50 0.29 0.27 0.34 0.40 0.53 0.46 0.72 0.50 0.37 0.34 0.25 0.16 0.14 0.17 0.19 0.20 0.00 0.26
Total liabilities 2.38 2.76 2.86 3.13 2.26 3.12 3.29 3.17 2.29 2.76 2.34 2.32 1.97 3.22 4.29 4.32 4.39 3.94 6.40 3.67 1.69 0.95 0.52 0.37 0.28 0.30 0.32 0.34 1.06 0.39
Total stockholders' equity + 18.72 19.22 18.48 18.51 18.93 19.41 19.11 19.07 19.97 20.25 19.87 19.91 22.02 20.06 18.37 16.83 15.91 11.89 10.10 5.48 2.52 1.37 0.93 0.60 0.45 0.49 0.42 0.38 0.27 0.27 -0.05
Common shares outstanding 253 245 239 242 240 240 245 238 241 241 240 240 245 246 256 259 260 260 260 259 257 245 241 232 223 230 229 229 227 227 227 194 194
about 2 months ago

Cash Flow - BioNTech SE (BNTX)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17
Operating cash flow + 0.44 0.21 5.37 13.58 0.89 -0.01 -0.20 -0.06 -0.05
Cash flow from investing + -2.37 -2.08 -6.95 -0.04 -0.57 -0.14 -0.08 -0.07 -0.05
Cash flow from financing + -0.05 -0.05 -0.78 -1.42 0.09 0.89 0.38 0.37 0.00
Change in cash -1.98 -1.92 -2.36 12.12 0.42 0.74 0.11 0.24 -0.11
Change in exchange rate 0.00 0.00 0.00
Show Quarterly Cash Flow

Cash Flow - BioNTech SE (BNTX)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Operating cash flow + -0.43 0.30 0.85 0.13 -0.82 -0.50 -0.69 1.76 -0.34 0.85 0.81 4.39 -0.68 0.83 4.78 3.92 4.05 -0.20 1.50 -0.10 -0.31 0.25 -0.19 -0.02 -0.05 -0.06 -0.05 -0.05 -0.03 0.00 0.01 -0.03 -0.03
Cash flow from investing + 2.69 -2.63 -1.00 -0.03 1.31 0.65 -0.16 -0.25 -2.50 -2.84 -1.23 -2.29 -0.74 -0.16 -0.08 -0.08 0.29 -0.47 -0.41 -0.03 -0.03 -0.10 -0.02 -0.01 -0.01 -0.01 -0.02 -0.01 -0.03 -0.02 -0.01 -0.02 -0.02
Cash flow from financing + 0.03 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.01 0.00 -0.31 -0.16 -0.29 -0.06 -0.65 -0.78 0.08 -0.05 -0.01 0.15 0.00 0.12 0.63 0.15 0.00 0.13 0.25 0.00 0.00 0.08 0.05 0.11 0.11
Change in cash 2.29 -2.34 -0.16 0.09 0.48 0.14 -0.86 1.49 -2.85 -1.99 -0.73 1.93 -1.70 0.60 4.04 3.06 4.42 -0.72 1.09 0.02 -0.34 0.27 0.42 0.12 -0.07 0.06 0.18 -0.06 -0.06 0.06 0.06 0.06 0.06
Change in exchange rate 0.00 0.00 0.00 0.00 0.00 0.00 0.00
about 2 months ago

BioNTech SE (BNTX) - Income Before Tax

1Y 2Y 5Y Max
about 2 months ago

BioNTech SE (BNTX) - Depreciation And Amortization

1Y 2Y 5Y Max
about 2 months ago

BioNTech SE (BNTX) - Interest Expense

1Y 2Y 5Y Max
about 2 months ago

BioNTech SE (BNTX) - Interest Income

1Y 2Y 5Y Max
about 2 months ago

BioNTech SE (BNTX) - Net Interest Income

1Y 2Y 5Y Max
about 2 months ago

BioNTech SE (BNTX) - Operating Expenses

1Y 2Y 5Y Max
about 2 months ago

BioNTech SE (BNTX) - Research And Development

1Y 2Y 5Y Max
about 2 months ago

BioNTech SE (BNTX) - Selling General And Administrative

1Y 2Y 5Y Max
about 2 months ago

BioNTech SE (BNTX) - Operating Income

1Y 2Y 5Y Max
about 2 months ago

BioNTech SE (BNTX) - Costof Goods And Services Sold

1Y 2Y 5Y Max
about 2 months ago